William Blair & Company
FLXN

William Blair & Company’s Flexion Therapeutics, Inc. FLXN Stock Holding History

William Blair & Company’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-160,399
Closed -$978K – 2045
2021
Q3 		$978K Buy
160,399
+10,299
+7% +$64.2K ﹤0.01% 932
2021
Q2 		$1.24M Buy
+150,100
New +$1.28M ﹤0.01% 852

William Blair & Company's FLXN Position: Q4 2021 in Review

William Blair & Company sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 160,399 shares — an estimated $978K sold.

William Blair & Company first reported a position in FLXN in Q2 2021 and held it in 2 quarters. The position peaked at $1.24M in Q2 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • William Blair & Company reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • William Blair & Company sold 160,399 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $978K.
  • William Blair & Company first reported a position in Flexion Therapeutics, Inc. in Q2 2021 and held it in 2 quarters.
  • William Blair & Company's Flexion Therapeutics, Inc. position peaked at $1.24M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.